GoldenGolden
Advanced Search
BravoVax

BravoVax

A biotechnology company that conducts research and development, manufactures, and markets human vaccines and other products. It was founded in 2012 and is located in Wuhan, China.

Company

BravoVax is a China-based biotechnology company specializing in developing vaccines such as the multivalent rotavirus vaccine and pneumococcal conjugate vaccine. It has five technology platforms to conduct its research which include bacterial fermentation, cell and virus culture, purification, formulation and quality control and are equipped with advanced instruments (such as fluorescent quantitative polymerase chain reaction).

COVID-19

In 2020, the company partnered with GeoVax, an American biotechnology company, to collaborate on the development of a COVID-19 vaccine. The company's role in the partnership included further development of the vaccine developed by its partner, including testing and manufacturing, as well as directing interactions with Chinese health authorities.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

GeoVax, BravoVax to develop vaccine for coronavirus

Web

January 30, 2020

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.